Short-term result of collagen crosslinking in pellucid marginal degeneration

Document Type : Original Article


Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran


Background: To evaluate effectiveness of collagen crosslinking in pellucid marginal degeneration patients.
Materials and Methods: Twenty-one eyes of 15 patients treated by collagen crosslinking were enrolled in our non-controlled clinical trial study. After evaluation of patients about inclusion and exclusion criteria, preoperative examination was done and then patients underwent CXL procedure and seen 6 months after surgery for postoperative examinations.
Results: Mean preoperative LogMar uncorrected visual acuity (UCVA) was 0.63 (SE = 0.08), and mean preoperative LogMar BCVA was 0.26 (SE = 0.04). At 6 months postoperative, mean LogMar UCVA was 0.59 (SE = 0.06) and mean LogMar BCVA was 0.19 (SE = 0.02). The non-parametric test (Wilcoxon) showed reduction of LogMar BCVA was significant (P value = 0.02), but reduction of LogMar UCVA was not significant (P value = 0.5). Mean preoperative K1 was 42.23 ± 2.85 and mean postoperative K1 significantly decreased to 41.68 ± 2.44 (P value = 0.008). Also, mean preoperative K2 was 48.39 ± 2.37 and mean postoperative K2 significantly reduced to 47.64 ± 2.16 (P value = 0.002).
Conclusion: Most remarkable findings of our study were improvement of visual acuity and reduction K1 and K2 parameters. Stability of other values and absence of detectable change after study period implies halting of the progression of the disease. We suggest CXL can be useful for management of PMD, but we need more studies with larger sample size and longer follow up.


Jinabhai A, Radhakrishnan H, O'Donnell C. Pellucid corneal marginal degeneration: A review. Contact Lens Anterior Eye 2011;34:56-63.  Back to cited text no. 1
Kubaloglu A, Sari ES, Cinar Y, Koytak A, Kurnaz E, Piñero DP, et al. A single 210-degree arc length intrastromal corneal ring implantation for the management of pellucid marginal corneal degeneration. Am J Ophthalmol 2010;150:185-92. e1.  Back to cited text no. 2
Kymionis GD, Karavitaki AE, Kounis GA, Portaliou DM, Yoo SH, Pallikaris IG. Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking. J Cataract Refract Surg 2009;35:1298-301.  Back to cited text no. 3
Gkika M, Labiris G, Kozobolis V. Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: A review of clinical and experimental studies. Int Ophthalmol 2011;31:309-19.  Back to cited text no. 4
Jankov Ii MR, Jovanovic V, Delevic S, Coskunseven E. Corneal collagen cross-linking outcomes: Review. Open Ophthalmol J 2011;5:19-20.  Back to cited text no. 5
Koller T, Pajic B, Vinciguerra P, Seiler T. Flattening of the cornea after collagen crosslinking for keratoconus. J Cataract Refract Surg 2011;37:1488-92.  Back to cited text no. 6
Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease-a review. Clin Experiment Ophthalmol 2010;38:141-53.  Back to cited text no. 7
Spadea L. Corneal collagen cross-linking with riboflavin and UVA irradiation in pellucid marginal degeneration. J Refract Surg 2010;26:375-7.  Back to cited text no. 8
Alpins NA. A new method of analyzing vectors for changes in astigmatism. J Cataract Refract Surg 1993;19:524-33.  Back to cited text no. 9
Stein R, Stein R, Honours B. Corneal collagen crosslinking: A major breakthrough in the management of keratoconus, pellucid marginal degeneration, and ectasia after LASIK. 2011;9:2.  Back to cited text no. 10
Koller T, Schumacher S, Fankhauser F 2nd, Seiler T. Riboflavin/ultraviolet a crosslinking of the paracentral cornea. Cornea 2013;32:165-8.  Back to cited text no. 11
Tuffaha BT, Alio JL, Piñero DP. Cross-linking for the management of pellucid marginal degeneration in a case of an unsuccessful implantation of intracorneal ring segments. IGKECD 2012;1:120-4.  Back to cited text no. 12
Stojanovic A, Zhang J, Chen X, Nitter TA, Chen S, Wang Q. Topography-guided transepithelial surface ablation followed by corneal collagen cross-linking performed in a single combined procedure for the treatment of keratoconus and pellucid marginal degeneration. J Refract Surg 2010;26:145-52.  Back to cited text no. 13